New Standard for Zoom, Magnification and Resolution in Stereomicroscopy Are Set.

Carl Zeiss has added a flagship stereomicroscope to its range with the launch of the SteREO Discovery.V20. The 20x zoom is the highest zoom factor and final magnification of any stereomicroscope available on the market. Thanks to the newly computed PlanApo S 2.3x objective, the SteREO Discovery.V20 also delivers the highest resolution in stereomicroscopy with 1000 LP/mm, with a maximum magnification of 345x (eyepieces 10x).

“The new microscope owes much of its exceptional optical performance to the CMO (common main objective) imaging system pioneered by Zeiss”, says Aubrey Lambert, marketing manager at Carl Zeiss UK. “The 20x zoom range enables users to move seamlessly from a panoramic overview of an object to examining extremely small details without any time-consuming change of objectives. This is a significant benefit in automated workflow environments. Furthermore, the high final magnification of the SteREO Discovery.V20 permits three-dimensional observation of objects that, until now, could only be examined two-dimensionally with a traditional light microscope.”

The advanced design guarantees safe object manipulation, combining high magnification with generous working distances. Ergonomically, every microscope function can be controlled through SyCoP, which integrates the entire System Control Panel into a mouse-like controller. This allows intuitive control of the motorised zoom and focus, the illumination, and the real-time display of total magnification, object field, resolution, depth of field and Z position.

A range of high-performance CMO lenses enables fine details to be visualised with outstanding contrast and in three dimensions. In combination with the Zeiss AxioCam digital microscope camera and Zeiss AxioVision image analysis and evaluation software, the SteREO Discovery.V20 is an outstanding image recording and analysis system, ideal for all branches of industry, from R&D through production to quality assurance, and for biomedical research.